Paper25201728
Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.
Mehta AY and 1 other. Biochem Biophys Res Commun, 2014. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2. Papers, record 25201728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25201728
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Lignin | Major topic |
| Thrombin | Major topic |
| Allosteric Regulation | |
| Catalytic Domain | |
| Heparin | |
| Kinetics | |
| Molecular Mimicry | |
| Platelet Glycoprotein GPIb-IX Complex | |
| Protein Binding | |
| Sodium Chloride | |
| Static Electricity | |
| Sulfates | |
| Thermodynamics |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HL107152 | NHLBI NIH HHS | United States | P01HL107152 | PubMed and NIH | NIH RePORTER |
| R01 HL090586 | NHLBI NIH HHS | United States | R01HL090586 | PubMed and NIH | NIH RePORTER |
| P01HL107152 | NHLBI NIH HHS | United States | P01HL107152 | PubMed and NIH | NIH RePORTER |
| R01 HL90586 | NHLBI NIH HHS | United States | R01HL090586 | PubMed and NIH | NIH RePORTER |
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24316004 | GpIbα interacts exclusively with exosite II of thrombin. | J Mol Biol | 2014 | https://conductscience.org/library/papers/24316004 | PubMed |
| 2 | 23809130 | The transition of prothrombin to thrombin. | J Thromb Haemost | 2013 | https://conductscience.org/library/papers/23809130 | PubMed |
| 3 | 24635452 | Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects. | J Med Chem | 2014 | https://conductscience.org/library/papers/24635452 | PubMed |
| 4 | 21555542 | Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21555542 | PubMed |
| 5 | 23718540 | Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition. | J Med Chem | 2013 | https://conductscience.org/library/papers/23718540 | PubMed |
| 6 | 21893043 | Identification of the site of binding of sulfated, low molecular weight lignins on thrombin. | Biochem Biophys Res Commun | 2011 | https://conductscience.org/library/papers/21893043 | PubMed |
| 7 | 21714536 | Rational design of potent, small, synthetic allosteric inhibitors of thrombin. | J Med Chem | 2011 | https://conductscience.org/library/papers/21714536 | PubMed |
| 8 | 10708869 | Regulation of blood coagulation. | Biochim Biophys Acta | 2000 | https://conductscience.org/library/papers/10708869 | PubMed |
| 9 | 15543318 | Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. | Thromb Haemost | 2004 | https://conductscience.org/library/papers/15543318 | PubMed |
| 10 | 21726912 | Allostery in trypsin-like proteases suggests new therapeutic strategies. | Trends Biotechnol | 2011 | https://conductscience.org/library/papers/21726912 | PubMed |
| 11 | 9184147 | Energetics of thrombin-thrombomodulin interaction. | Biochemistry | 1997 | https://conductscience.org/library/papers/9184147 | PubMed |
| 12 | 24516370 | A unified view of "how allostery works". | PLoS Comput Biol | 2014 | https://conductscience.org/library/papers/24516370 | PubMed |
| 13 | 10660541 | The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10660541 | PubMed |
| 14 | 17804413 | A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17804413 | PubMed |
| 15 | 21238936 | Thrombin as an anticoagulant. | Prog Mol Biol Transl Sci | 2011 | https://conductscience.org/library/papers/21238936 | PubMed |
| 16 | 16728654 | Thrombin-cofactor interactions: structural insights into regulatory mechanisms. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16728654 | PubMed |
| 17 | 1003464 | Ion effects on ligand-nucleic acid interactions. | J Mol Biol | 1976 | https://conductscience.org/library/papers/1003464 | PubMed |
| 18 | 9516447 | Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9516447 | PubMed |
| 19 | 1450405 | Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity. | Blood | 1992 | https://conductscience.org/library/papers/1450405 | PubMed |
| 20 | 16241939 | Determinants of specificity in coagulation proteases. | J Thromb Haemost | 2005 | https://conductscience.org/library/papers/16241939 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37001055 | Designing Smaller, Synthetic, Functional Mimetics of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation Factors. | J Med Chem | 2023 | https://conductscience.org/library/papers/37001055 | PubMed |
| 30931428 | Allosteric inhibition of α-thrombin enzymatic activity with ultrasmall gold nanoparticles. | Nanoscale Adv | 2019 | https://conductscience.org/library/papers/30931428 | PubMed |
| 30457046 | Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/30457046 | PubMed |
| 30337351 | A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. | Mol Cancer Ther | 2019 | https://conductscience.org/library/papers/30337351 | PubMed |
| 29573721 | Novel heparin mimetics reveal cooperativity between exosite 2 and sodium-binding site of thrombin. | Thromb Res | 2018 | https://conductscience.org/library/papers/29573721 | PubMed |
| 27053426 | Allosteric Partial Inhibition of Monomeric Proteases. Sulfated Coumarins Induce Regulation, not just Inhibition, of Thrombin. | Sci Rep | 2016 | https://conductscience.org/library/papers/27053426 | PubMed |
| 26748875 | Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin. | J Thromb Haemost | 2016 | https://conductscience.org/library/papers/26748875 | PubMed |
| 26083038 | Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases. | Molecules | 2015 | https://conductscience.org/library/papers/26083038 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F2 | 2147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| GP1BA | 2811 | PubTator's text mining | https://conductscience.org/library/genes/2811 | NCBI Gene |
| THBD | 7056 | PubTator's text mining | https://conductscience.org/library/genes/7056 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25201728
GET https://conductscience.org/api/papers/v1/25201728/references?page=2